首站-论文投稿智能助手
典型文献
Discovery of novel MIF inhibitors that attenuate microglial inflammatory activation by structures-based virtual screening and in vitro bioassays
文献摘要:
Macrophage migration inhibitory factor(MIF)is a pluripotent pro-inflammatory cytokine and is related to acute and chronic inflammatory responses,immune disorders,tumors,and other diseases.In this study,an integrated virtual screening strategy and bioassays were used to search for potent MIF inhibitors.Twelve compounds with better bioactivity than the prototypical MIF-inhibitor ISO-1(IC50=14.41 μM)were identified by an in vitro enzymatic activity assay.Structural analysis revealed that these inhibitors have novel structural scaffolds.Compound 11 was then chosen for further characterization in vitro,and it exhibited marked anti-inflammatory efficacy in LPS-activated BV-2 microglial cells by suppressing the activation of nuclear factor kappa B(NF-κB)and mitogen-activated protein kinases(MAPKs).Our findings suggest that MIF may be involved in the regulation of microglial inflammatory activation and that small-molecule MIF inhibitors may serve as promising therapeutic agents for neuroinflammatory diseases.
文献关键词:
作者姓名:
Yu Zhang;Lei Xu;Yao Zhang;Jie Pan;Pu-qing Wang;Sheng Tian;Huan-ting Li;Bo-wen Gao;Ting-jun Hou;Xue-chu Zhen;Long-Tai Zheng
作者机构:
Department of Pharmacy,Hubei Clinical Research Center of Parkinson's disease,Xiangyang Key Laboratory of Movement Disorders,Xiangyang No.1 People'Hospital,Hubei University of Medicine,Xiangyang 441000,China;Institute of Bioinformatics and Medical Engineering,Jiangsu University of Technology,Changzhou 213001,China;Jiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences,Soochow University,Suzhou 215123,China;School of Pharmacy,Baotou Medical College,Baotou 014060,China;College of Pharmaceutical Sciences,Zhejiang University,Hangzhou 310058,China
引用格式:
[1]Yu Zhang;Lei Xu;Yao Zhang;Jie Pan;Pu-qing Wang;Sheng Tian;Huan-ting Li;Bo-wen Gao;Ting-jun Hou;Xue-chu Zhen;Long-Tai Zheng-.Discovery of novel MIF inhibitors that attenuate microglial inflammatory activation by structures-based virtual screening and in vitro bioassays)[J].中国药理学报(英文版),2022(06):1508-1520
A类:
B类:
Discovery,novel,MIF,inhibitors,that,attenuate,microglial,activation,by,structures,virtual,screening,vitro,bioassays,Macrophage,migration,inhibitory,pluripotent,cytokine,related,acute,chronic,responses,immune,disorders,tumors,other,diseases,In,this,study,integrated,strategy,were,used,search,Twelve,compounds,better,bioactivity,than,prototypical,ISO,IC50,identified,enzymatic,Structural,analysis,revealed,these,have,structural,scaffolds,Compound,was,then,chosen,further,characterization,exhibited,marked,anti,efficacy,LPS,activated,BV,cells,suppressing,nuclear,kappa,mitogen,protein,kinases,MAPKs,Our,findings,suggest,may,involved,regulation,small,molecule,serve,promising,therapeutic,agents,neuroinflammatory
AB值:
0.607708
相似文献
Efficacy of Moxa-burning heat stimulating Zusanli(ST36)and Shenshu(BL23)on expressions of macrophage migration inhibitory factor and macrophage apoptosis in rabbits with adjuvant-induced arthritis
ZHOU Haiyan;ZHONG Yumei;GAO Xiuhua;WU Fei;JIA Min;YANG Xin-School of Acupuncture-Moxibustion and Tuina,Chengdu University of Traditional Chinese Medicine,Chengdu 610075,China;Pain Department,Chengdu First People's Hospital/Chengdu Integrated TCM&Western Medicine Hospital,Chengdu 610095,China;Centre of Preventive Treatment of Disease,Teaching Hospital of Chengdu University of Traditional Chinese Medicine,Chengdu 610075,China;Foreign Languages School,Chengdu University of Traditional Chinese Medicine,Chengdu 610075,China;Acupuncture Department,Second Affiliated Hospital of Baotou Medical College,Baotou 014030,China;Health Rehabilitation School,Chengdu University of Traditional Chinese Medicine,Chengdu 610075,China
Taxifolin attenuates inflammation via suppressing MAPK signal pathway in vitro and in silico analysis
Xingyan Zhang;Xiaoyan Lian;Huling Li;Wenjing Zhao;Xin Li;Fujun Zhou;Yutong Zhou;Tao Cui;Yuli Wang;Changxiao Liu-Key Laboratory of Quality-marker of Traditional Chinese Medicines,Tianjin Institute of Pharmaceutical Research Co.,Ltd.,Tianjin 300462,China;Center for Drug Evaluation,National Medical Products Administration,Beijing 100022,China;Department of Pharmacology,Tianjin Medical University,Tianjin 300070,China;State Key Laboratory of Drug Delivery Technology and Pharmacokinetics,Tianjin Institute of Pharmaceutical Research Co.,Ltd.,Tianjin 300462,China;Key Laboratory of Systems Bioengineering(Ministry of Education),School of Chemistry Engineering and Technology,Tianjin University,Tianjin 300072,China;Pharmaceuticai Armaceuticai DA REN TANG Group Corporation Limited Traditional Chinese Pharmacy Researchinstitute,Tianjin 300457,China;Tianjin Key Laboratory of Quality Control in Chinese Medicine,Tianjin 300457,China;Research Unit for Drug Metabolism,Chinese Academy of Medical Sciences,Beijing 100730,China
Targeting a cryptic allosteric site of SIRT6 with small-molecule inhibitors that inhibit the migration of pancreatic cancer cells
Qiufen Zhang;Yingyi Chen;Duan Ni;Zhimin Huang;Jiacheng Wei;Li Feng;Jun-Cheng Su;Yingqing Wei;Shaobo Ning;Xiuyan Yang;Mingzhu Zhao;Yuran Qiu;Kun Song;Zhengtian Yu;Jianrong Xu;Xinyi Li;Houwen Lin;Shaoyong Lu;Jian Zhang-State Key Laboratory of Oncogenes and Related Genes,Department of Pharmacy,Renji Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200127,China;Medicinal Chemistry and Bioinformatics Center Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Nutshell Therapeutics,Shanghai 201203,China;Academy of Integrative Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;School of Pharmaceutical Sciences,Zhengzhou University,Zhengzhou 450001,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。